GRAIL Securities Class Action
GRAIL · GRAIL common stock and the NHS-Galleri cancer screening trial
A federal securities class action alleges that Grail and its executives made false or misleading statements to investors about the likelihood that the NHS-Galleri cancer detection trial would achieve its primary endpoint while allegedly concealing concerns about the trial's duration and screening period. The action was filed and was in ongoing litigation, with an August 4, 2026 deadline for investors to seek appointment as lead plaintiff.
Case updates and reports
How to participate
Grail Lead Plaintiff Application
Investors who purchased or acquired Grail stock between May 13, 2025 and February 19, 2026 and suffered financial losses were described as potential lead-plaintiff applicants.
- Type
- Lead Plaintiff
- Lead plaintiff status
- Deadline passed
- Reported proof requirement
- Unclear
Lead plaintiff and case participation inquiry
Investors who purchased GRAIL securities during the stated class period of May 13, 2025, through February 19, 2026, were invited to contact Schall Brown & Schwartz about eligibility or serving as lead plaintiff.
- Type
- Law Firm Signup
- Law firm signup
- Deadline passed
- Reported proof requirement
- Unclear
Faruqi & Faruqi investor inquiry
Investors who suffered losses in Grail, as well as people with information about Grail’s conduct, are encouraged to contact Faruqi & Faruqi.
- Type
- Law Firm Signup
- Law firm signup
- Unknown
Bronstein, Gewirtz & Grossman investor inquiry
The article invites GRAIL investors to contact the law firm regarding the securities class action, but does not specify eligibility requirements.
- Type
- Law Firm Signup
- Law firm signup
- Unknown
- Reported proof requirement
- Unclear
Grail Investor Legal Rights Inquiry
The law firm invites individuals who purchased Grail shares between May 13, 2025 and February 19, 2026 and experienced an investment loss to discuss their legal rights.
- Type
- Law Firm Signup
- Law firm signup
- Unknown
- Reported proof requirement
- Unclear
GRAIL Class Action Legal Consultation
People who purchased or acquired GRAIL common stock between May 13, 2025, and February 19, 2026, are invited to discuss their legal rights with the law firm.
- Type
- Law Firm Signup
- Law firm signup
- Unknown
- Reported proof requirement
- Unclear
Lead Plaintiff Inquiry
Investors who suffered substantial losses may provide their information to inquire about serving as lead plaintiff.
- Type
- Law Firm Signup
- Law firm signup
- Unknown
Pomerantz investor inquiry
Investors with losses on their investment in GRAIL are invited to contact Pomerantz LLP regarding the lawsuit.
- Type
- Law Firm Signup
- Law firm signup
- Unknown
- Reported proof requirement
- Unclear